Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × QGP-1 cells, shControl vs 3 × QGP-1 cells, shSIRT7 vs 3 × BON-1 cells, Parental vs 3 × BON-1 cells, RadioresistantGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 ExpressionAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE323363_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1432533 and SRA study SRP681170. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9564346 QGP-1 cells, shControl R1 QGP-1 cells, shControl
- GSM9564347 QGP-1 cells, shControl R2 QGP-1 cells, shControl
- GSM9564348 QGP-1 cells, shControl R3 QGP-1 cells, shControl
- GSM9564349 QGP-1 cells, shSIRT7 R1 QGP-1 cells, shSIRT7
- GSM9564350 QGP-1 cells, shSIRT7 R2 QGP-1 cells, shSIRT7
- GSM9564351 QGP-1 cells, shSIRT7 R3 QGP-1 cells, shSIRT7
- GSM9564352 BON-1 cells, Parental R1 BON-1 cells, Parental
- GSM9564353 BON-1 cells, Parental R2 BON-1 cells, Parental
- GSM9564354 BON-1 cells, Parental R3 BON-1 cells, Parental
- GSM9564355 BON-1 cells, Radioresistant R1 BON-1 cells, Radioresis…
- GSM9564356 BON-1 cells, Radioresistant R2 BON-1 cells, Radioresis…
- GSM9564357 BON-1 cells, Radioresistant R3 BON-1 cells, Radioresis…
- GSE252569 CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation 68 samples shares neuroendocrine, inhibition
- GSE252568 CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation III 42 samples shares neuroendocrine, inhibition
- GSE281039 Molecular characterization of pancreatic neuroendocrine tumor tissue: characterization of altered pathways and potential non-invasive biomarkers 40 samples shares neuroendocrine, pancreatic
- GSE296486 Tumor-derived Apolipoprotein E induces Tip endothelial cell to remodel tumor stroma ratio and promote pancreatic neuroendocrine tumor progression 34 samples shares neuroendocrine, pancreatic
- GSE301075 Immunosuppressive myeloid signaling and distinct malignant cell states in pancreatic neuroendocrine tumors revealed by single-nucleus RNA-seq 21 samples shares neuroendocrine, pancreatic
- GSE252567 CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation II 14 samples shares neuroendocrine, inhibition
- GSE280271 Deep sequencing of microRNA and total RNA reveals distinct microRNA-mRNA signatures that differentiate pancreatic neuroendocrine neoplasia from non-diseased pancreas tissue [RNA-seq] 13 samples shares neuroendocrine, pancreatic
- GSE267722 MUC1-C DEPENDENCE FOR PROGRESSION OF PANCREATIC NEUROENDOCRINE TUMORS IDENTIFIES A DRUGGABLE TARGET FOR TREATMENT OF THIS RARE CANCER 12 samples shares neuroendocrine, pancreatic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.